AtriCure (ATRC) insider plans Rule 144 sale of 6,182 common shares

Rhea-AI Filing Summary

AtriCure, Inc. filed a notice of proposed sale of common stock under Rule 144. The filing lists a planned sale of 6,182 shares of common stock through RBC Capital Markets LLC on the NASDAQ market, associated with an aggregate value of $239,882.00. The shares to be sold were acquired via stock grants of 2,712 shares on March 1, 2023 and 3,470 shares on March 1, 2024.

Key Figures

Shares to be sold: 6,182 shares Aggregate value: $239,882.00 Stock grant 2023: 2,712 shares +2 more

5 metrics

Shares to be sold 6,182 shares Common stock proposed for sale under Rule 144

Aggregate value $239,882.00 Value associated with 6,182 shares of common stock

Stock grant 2023 2,712 shares Stock grant dated 03/01/2023

Stock grant 2024 3,470 shares Stock grant dated 03/01/2024

Associated date 07/29/2026 Date tied to proposed NASDAQ sale of common stock

Key Terms

Rule 144, stock grant, aggregate value

3 terms

Rule 144 regulatory

"filed a notice of proposed sale of common stock under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock grant financial

"shares to be sold were acquired via stock grants of 2,712 shares"

A stock grant is an award of company shares given to an individual, often as part of compensation for employees or executives. It matters to investors because grants can change the number of shares outstanding (dilution) and signal how company leaders are being paid and motivated—think of it like receiving a slice of the company as part of your paycheck, which can affect ownership and future share supply.

aggregate value financial

"associated with an aggregate value of $239,882.00"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/29/2026 - 02:23 PM Accepted by SEC EDGAR 07/29/2026 - 02:23 PM Learn about SEC filing dates

FAQ

What does AtriCure (ATRC) disclose in this Form 144 filing?

AtriCure discloses a planned sale of 6,182 common shares under Rule 144, with an indicated aggregate value of $239,882.00. The sale is to be executed through RBC Capital Markets LLC on NASDAQ.

How many AtriCure (ATRC) shares are proposed to be sold and at what value?

The filing lists a proposed sale of 6,182 common shares of AtriCure, Inc. with an aggregate value of $239,882.00. These figures are disclosed as part of a Rule 144 planned sale notice.

Who is the broker for the AtriCure (ATRC) Rule 144 stock sale?

The broker listed is RBC Capital Markets LLC, located at 250 Nicollet Mall, Suite 1700, Minneapolis, MN 55401. The filing indicates the common shares will be sold on the NASDAQ market through this broker.

What is the origin of the AtriCure (ATRC) shares being sold under Rule 144?

The shares originate from stock grants: 2,712 shares granted on March 1, 2023 and 3,470 shares granted on March 1, 2024. These grants together correspond to the 6,182 shares planned for sale.

On what date is the AtriCure (ATRC) Rule 144 sale associated in the filing?

The Rule 144 disclosure associates the proposed sale with the date 07/29/2026. This date appears in the section detailing the common stock to be sold on NASDAQ through RBC Capital Markets LLC.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RBC CAPITAL MARKETS LLC 250 NICOLLET MALL, SUITE 1700 MINNEAPOLIS MN 55401	6182	239882.00	50866294	07/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/01/2023	STOCK GRANT	ISSUER			2712	03/01/2023	N/A
COMMON	03/01/2024	STOCK GRANT	ISSUER			3470	03/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)